Security key
207523101
Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (CNTB)
CUSIP: 207523101
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Ordinary shares, par value $0.000174
- Shares outstanding
- 62,516,710
- Total 13F shares
- 10,358,458
- Share change
- -560,657
- Total reported value
- $11,684,999
- Price per share
- $1.11
- Number of holders
- 15
- Value change
- -$631,607
- Number of buys
- 4
- Number of sells
- 7
Report period
Q2 2023
Institutions
15
Top holders
10
CNTB full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Connect Biopharma Holdings Ltd SEC filings
Connect Biopharma Holdings Ltd company facts
Broader feeds
Reporting periods
Holder history for CUSIP 207523101
Recent filing periods:
Top shareholders of CNTB - Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
11%
|
6,991,003
|
$6,990,304 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.8%
|
1,125,262
|
$1,125,149 | — | 31 Mar 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.6%
|
1,027,519
|
$1,027,416 | — | 31 Mar 2023 | |
| Kynam Capital Management, LP |
13F
|
Company |
1.2%
|
739,649
|
$739,575 | — | 31 Mar 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.92%
|
574,148
|
$574,148 | — | 31 Mar 2023 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.35%
|
219,501
|
$219,479 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.14%
|
89,100
|
$89,000 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.13%
|
78,547
|
$79,000 | — | 31 Mar 2023 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
26,867
|
$26,864 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.03%
|
20,670
|
$20,668 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
19,032
|
$19,030 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
9,336
|
$9,336 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
0%
|
33
|
$33 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
2
|
$2 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Mar 2023 |
Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (CNTB) as of Q2 2023
As of 30 Jun 2023,
Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (CNTB) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,358,458 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., UBS OCONNOR LLC, Kynam Capital Management, LP, Ikarian Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, JPMORGAN CHASE & CO, BOOTHBAY FUND MANAGEMENT, LLC, and TWO SIGMA INVESTMENTS, LP.
This page lists
15
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
15
Q2 2023 holders
15
Holder diff
0
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.